The box office numbers tell a familiar story, and not in a good way. While "Spider-Man: Brand New Day" dominates theaters in its third weekend, pulling in $67 million, we should ask ourselves a harder question: What happens to the original screenplays that don't have a built-in fanbase willing to show up regardless of quality?

Look at the broader pattern. The studios know exactly what they're doing. They greenlight films with recognizable IP because the financial risk feels manageable. A Spider-Man sequel will make money. A Star Wars spinoff has a floor. But an original drama or a fresh genre film? That's treated like venture capital speculation, not filmmaking.

This is where the incentive structure becomes corrosive.

When a studio executive can greenlight the tenth iteration of a franchise and claim victory if it merely performs above projections, they've insulated themselves from real accountability. The box office becomes a self-fulfilling prophecy: audiences see the same franchises everywhere, so they go to those films, which then justifies the studio's next round of sequels. Original stories get smaller marketing budgets, narrower releases, and later time slots. Then when they underperform, executives nod knowingly: "See? Original content doesn't work."

Consider what this means for filmmakers. A director with a unique vision has to fight for scraps. Meanwhile, the studio's C-tier franchise reboot gets a $150 million budget and prime real estate. The message to writers and directors is unmistakable: Your ideas matter less than our existing properties. This isn't sustainable for the health of cinema as an art form, even if Wall Street doesn't care.

The Academy's recent moves toward theatrical standards and marquee listings suggest at least some institutional awareness that theatrical film needs defending. But that's a Band-Aid on a systemic problem. You can't protect cinema's future by tweaking the presentation of the same recycled narratives.

What's particularly galling is the false scarcity argument. Studios claim they can't afford to take risks on original content. Yet somehow, they find resources for the third sequel nobody asked for, or the legacy IP reboot that will alienate existing fans. The money exists. The willingness doesn't.

The real beneficiaries of this arrangement aren't filmmakers or audiences. They're shareholders and the executives whose bonuses depend on predictable quarterly earnings. A $20 million original film that breaks even looks like a failure next to a $200 million franchise installment that underperforms but still clears $500 million globally. The optics are terrible, so the studios avoid the bet entirely.

Meanwhile, the creative ecosystem atrophies. Young screenwriters learn to write fan fiction instead of original stories because that's where the development deals are. Directors cut their teeth on sequels rather than personal projects. The pipeline for fresh voices gets narrower.

This isn't an argument against franchise filmmaking entirely. Those movies employ thousands and bring genuine joy to audiences. But when the entire system is architected to reward franchise output above all else, something gets sacrificed. It's the possibility of discovering something we didn't know we needed to see.

The box office is a mirror, but it's also a choice. Studios choose what gets made. They choose what gets marketed. They choose what gets theater space. For too long, they've chosen the safe bet, then acted surprised when audiences grow bored.

The irony is that the occasional original film that does break through, like the concert documentaries and unexpected hits, performs better precisely because it offers something different. The market rewards novelty when novelty is given a fair shot.

Until the incentive structure changes, don't expect that to happen anytime soon.